Published in Med Microbiol Immunol on January 01, 1986
Genetic diversity among Lassa virus strains. J Virol (2000) 3.00
Geographic distribution and genetic diversity of Whitewater Arroyo virus in the southwestern United States. Emerg Infect Dis (2001) 1.44
Nipah virus: a recently emergent deadly paramyxovirus. Science (2000) 9.39
Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness. Science (1993) 9.11
Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. The Hantavirus Study Group. N Engl J Med (1994) 7.61
The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidémies à Kikwit. J Infect Dis (1999) 7.39
The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing. Proc Natl Acad Sci U S A (1996) 7.02
Climate and satellite indicators to forecast Rift Valley fever epidemics in Kenya. Science (1999) 6.94
Transmission of Ebola hemorrhagic fever: a study of risk factors in family members, Kikwit, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidémies à Kikwit. J Infect Dis (1999) 6.72
Hemorrhagic fever viruses as biological weapons: medical and public health management. JAMA (2002) 6.59
Lassa fever. Effective therapy with ribavirin. N Engl J Med (1986) 6.38
Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients. Nat Med (1999) 5.85
Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: clinical observations in 103 patients. J Infect Dis (1999) 5.59
A prospective study of the epidemiology and ecology of Lassa fever. J Infect Dis (1987) 5.27
Human asymptomatic Ebola infection and strong inflammatory response. Lancet (2000) 5.20
Clinical virology of Ebola hemorrhagic fever (EHF): virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis (1999) 4.96
Ebola virus disease in southern Sudan: hospital dissemination and intrafamilial spread. Bull World Health Organ (1983) 4.81
Persistence and genetic stability of Ebola virus during the outbreak in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis (1999) 4.28
Longitudinal cohort study of the epidemiology of malaria infections in an area of intense malaria transmission II. Descriptive epidemiology of malaria infection and disease among children. Am J Trop Med Hyg (1999) 4.24
Experimental inoculation of plants and animals with Ebola virus. Emerg Infect Dis (1997) 4.03
ELISA for the detection of antibodies to Ebola viruses. J Infect Dis (1999) 3.92
Sequence analysis of the Ebola virus genome: organization, genetic elements, and comparison with the genome of Marburg virus. Virus Res (1993) 3.89
Evaluation of immune globulin and recombinant interferon-alpha2b for treatment of experimental Ebola virus infections. J Infect Dis (1999) 3.62
Preliminary report: isolation of Ebola virus from monkeys imported to USA. Lancet (1990) 3.55
A case-control study of the clinical diagnosis and course of Lassa fever. J Infect Dis (1987) 3.51
Patterns of association with host and habitat: antibody reactive with Sin Nombre virus in small mammals in the major biotic communities of the southwestern United States. Am J Trop Med Hyg (1997) 3.46
Ebola virus can be effectively neutralized by antibody produced in natural human infection. J Virol (1999) 3.44
Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epidémies à Kikwit. J Infect Dis (1999) 3.36
Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995: determinants of survival. J Infect Dis (1999) 3.34
Review of cases of nosocomial Lassa fever in Nigeria: the high price of poor medical practice. BMJ (1995) 3.21
Genetic diversity among Lassa virus strains. J Virol (2000) 3.00
Biochemical analysis of the secreted and virion glycoproteins of Ebola virus. J Virol (1998) 2.99
Measurement of antibodies to Machupo virus by the indirect fluorescent technique. Proc Soc Exp Biol Med (1973) 2.97
Clinical virology of Lassa fever in hospitalized patients. J Infect Dis (1987) 2.94
Inflammatory responses in Ebola virus-infected patients. Clin Exp Immunol (2002) 2.79
Laguna Negra virus associated with HPS in western Paraguay and Bolivia. Virology (1997) 2.78
Markedly elevated levels of interferon (IFN)-gamma, IFN-alpha, interleukin (IL)-2, IL-10, and tumor necrosis factor-alpha associated with fatal Ebola virus infection. J Infect Dis (1999) 2.76
Rescue of infectious rift valley fever virus entirely from cDNA, analysis of virus lacking the NSs gene, and expression of a foreign gene. J Virol (2006) 2.73
Mutagen-directed attenuation of Rift Valley fever virus as a method for vaccine development. J Gen Virol (1985) 2.71
Enzyme immunosorbent assay for Ebola virus antigens in tissues of infected primates. J Clin Microbiol (1992) 2.69
Passive immunization of Ebola virus-infected cynomolgus monkeys with immunoglobulin from hyperimmune horses. Arch Virol Suppl (1996) 2.69
Molecular investigation of a multisource outbreak of Crimean-Congo hemorrhagic fever in the United Arab Emirates. Am J Trop Med Hyg (1997) 2.66
Descriptive analysis of Ebola virus proteins. Virology (1985) 2.65
Hantavirus pulmonary syndrome: the first 100 US cases. J Infect Dis (1996) 2.64
Detection of human immunoglobulins G and M antibodies to Rift Valley fever virus by enzyme-linked immunosorbent assay. J Clin Microbiol (1984) 2.61
Lassa fever in the United States. Investigation of a case and new guidelines for management. N Engl J Med (1990) 2.57
Utilization of autopsy RNA for the synthesis of the nucleocapsid antigen of a newly recognized virus associated with hantavirus pulmonary syndrome. Virus Res (1993) 2.57
Characterization of filoviruses based on differences in structure and antigenicity of the virion glycoprotein. Virology (1994) 2.48
Parasitic, bacterial, and viral enteric pathogens associated with diarrhea in the Central African Republic. J Clin Microbiol (1984) 2.46
Inactivation of Lassa, Marburg, and Ebola viruses by gamma irradiation. J Clin Microbiol (1982) 2.44
First field evidence for natural vertical transmission of West Nile virus in Culex univittatus complex mosquitoes from Rift Valley province, Kenya. Am J Trop Med Hyg (2000) 2.44
Cytoplasmic compartmentalization of the protein and ribonucleic acid species of vesicular stomatitis virus. J Virol (1972) 2.37
Long-term studies of hantavirus reservoir populations in the southwestern United States: a synthesis. Emerg Infect Dis (1999) 2.36
Phylogenetic analysis of the Arenaviridae: patterns of virus evolution and evidence for cospeciation between arenaviruses and their rodent hosts. Mol Phylogenet Evol (1997) 2.36
Unsafe injections and the transmission of hepatitis B and C in a periurban community in Pakistan. Bull World Health Organ (2000) 2.33
Marburg virus, a filovirus: messenger RNAs, gene order, and regulatory elements of the replication cycle. Virus Res (1992) 2.29
A reassortant bunyavirus isolated from acute hemorrhagic fever cases in Kenya and Somalia. Virology (2001) 2.28
Ebola hemorrhagic fever, Kikwit, Democratic Republic of the Congo, 1995: risk factors for patients without a reported exposure. J Infect Dis (1999) 2.27
The relationship between therapeutic injections and high prevalence of hepatitis C infection in Hafizabad, Pakistan. Epidemiol Infect (1997) 2.27
Brief report: treatment of a laboratory-acquired Sabiá virus infection. N Engl J Med (1995) 2.27
Identification of a new North American hantavirus that causes acute pulmonary insufficiency. Am J Trop Med Hyg (1995) 2.26
Epidemiology of Ebola (subtype Reston) virus in the Philippines, 1996. J Infect Dis (1999) 2.22
An unusual hantavirus outbreak in southern Argentina: person-to-person transmission? Hantavirus Pulmonary Syndrome Study Group for Patagonia. Emerg Infect Dis (1997) 2.19
Rift Valley fever virus NSs protein promotes post-transcriptional downregulation of protein kinase PKR and inhibits eIF2alpha phosphorylation. PLoS Pathog (2009) 2.17
Pathologic and virologic study of fatal Lassa fever in man. Am J Pathol (1982) 2.14
Ribavirin suppresses replication of lymphadenopathy-associated virus in cultures of human adult T lymphocytes. Lancet (1984) 2.12
Pathogenesis of a North American hantavirus, Black Creek Canal virus, in experimentally infected Sigmodon hispidus. Am J Trop Med Hyg (1998) 2.11
The phylogeny of New World (Tacaribe complex) arenaviruses. Virology (1996) 2.11
Type 2 diabetes and tuberculosis in a dynamic bi-national border population. Epidemiol Infect (2006) 2.09
Lassa fever in Guinea: I. Epidemiology of human disease and clinical observations. Vector Borne Zoonotic Dis (2001) 2.07
A real-time RT-PCR method for the universal detection and identification of flaviviruses. Vector Borne Zoonotic Dis (2007) 2.05
Detection and molecular characterization of Ebola viruses causing disease in human and nonhuman primates. J Infect Dis (1999) 2.04
Hantavirus pulmonary syndrome in Panama: identification of novel hantaviruses and their likely reservoirs. Virology (2000) 2.03
Acute sensorineural deafness in Lassa fever. JAMA (1990) 2.02
Genome structure and variability of a virus causing hantavirus pulmonary syndrome. Virology (1994) 2.01
Direct genetic detection of Dobrava virus in Greek and Albanian patients with hemorrhagic fever with renal syndrome. J Infect Dis (1996) 1.99
Simian immunodeficiency viruses from central and western Africa: evidence for a new species-specific lentivirus in tantalus monkeys. J Virol (1993) 1.98
A novel immunohistochemical assay for the detection of Ebola virus in skin: implications for diagnosis, spread, and surveillance of Ebola hemorrhagic fever. Commission de Lutte contre les Epidémies à Kikwit. J Infect Dis (1999) 1.96
Biologic differences between strains of Ebola virus from Zaire and Sudan. J Infect Dis (1983) 1.94
NSm protein of Rift Valley fever virus suppresses virus-induced apoptosis. J Virol (2007) 1.94
Junin virus monoclonal antibodies: characterization and cross-reactivity with other arenaviruses. J Gen Virol (1989) 1.92
Genetic investigation of novel hantaviruses causing fatal HPS in Brazil. J Med Virol (1999) 1.92
General aspects of the 1987 Rift Valley fever epidemic in Mauritania. Res Virol (1989) 1.91
Rift valley fever virus nonstructural protein NSs promotes viral RNA replication and transcription in a minigenome system. J Virol (2005) 1.90
Filoviridae: a taxonomic home for Marburg and Ebola viruses? Intervirology (1982) 1.89
Using remotely sensed data to identify areas at risk for hantavirus pulmonary syndrome. Emerg Infect Dis (2000) 1.88
Isolation and characterization of Whitewater Arroyo virus, a novel North American arenavirus. Virology (1996) 1.87
Genetic analysis of the diversity and origin of hantaviruses in Peromyscus leucopus mice in North America. J Virol (1998) 1.87
A longitudinal study of Junin virus activity in the rodent reservoir of Argentine hemorrhagic fever. Am J Trop Med Hyg (1992) 1.86
Ribonucleic acid species of intracellular nucleocapsids and released virions of vesicular stomatitis virus. J Virol (1972) 1.86
Identification and analysis of Ebola virus messenger RNA. Virology (1987) 1.84
Experimental studies of arenaviral hemorrhagic fevers. Curr Top Microbiol Immunol (1987) 1.83
NSm and 78-kilodalton proteins of Rift Valley fever virus are nonessential for viral replication in cell culture. J Virol (2006) 1.81